Dextromethorphan and guaifenesin use should be monitored diligently in individuals with "inadequate metabolizer" CYP2D6 enzyme ranges and patients who are sedated. This mixture medication incorporates a huge median toxic dose (TD50) to median helpful dose (ED50) ratio (or therapeutic index) in these individuals. 资助维基百科 外观 创建账号 登录 个人工具 创建账号 This https://hireaprofessionalhacker13567.win-blog.com/10248733/details-fiction-and-dextromethorphan-dxm-for-sale-in-copyright